Indium In-111 satumomab pendetide

Identification

Name
Indium In-111 satumomab pendetide
Accession Number
DB00057 / 7V9926378A
Groups
Description

Tumor related glycoprotein (TAG) seventy two (B72.3) monoclonal antibody conjugated with Indium 111 for radioimaging colon tumors. Satumomab Pendetide (alternate call: OncoScint®) is no longer commercially available.

Pharmacology

Pharmacodynamics

Binds to the tumor associated glycoprotein 72 antigen, which is a cell surface protein generally over-expressed in colorectal cancers. The radioactive Indium 111, which is covalently attached to the antibody, allows radiodiagnostic detection of TAG-72 expressing cells and tumors.

Indication

For diagnosis of extrahepatic malignant cancers

Action

Satumomab Pendetide is a monoclonal antibody which is attached to the chelator pentetic acid (DTPA) linked to the tripeptide glycine (G) – L-tyrosine (Y) – L-lysine (K), which chelates Indium 111. Satumomab pendetide binds selectively to cell-surface TAG-72 expressed on colorectal tumors.